phenelfamycin E

(2E,4E,6E)-7-{(2S,3S,5R)-5-[(2S,3S,4E,6E)-8-{[(2S)-2-[(2R,3R,4R,6S)-2,4-Dihydroxy-5,5-dimethyl-6-[(1E,3Z)-1,3-pentadien-1-yl]-3-(2-phenylacetoxy)tetrahydro-2H-pyran-2-yl]-3-{[(2R,4S,5R,6S)-5-{[(2R,4R, 5S,6S)-5-{[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}propanoyl]amino}-3-met hoxy-4-methyl-4,6-octadien-2-yl]-3-hydroxytetrahydro-2-furanyl}-2,4,6-heptatrienoic acid (non-preferred name)

114451-31-9

phenelfamycin E

(2E,4E,6E)-7-[(2S,3S,5R)-5-[(2S,3S,4E,6E)-8-[[(2S)-2-[(2R,3R,4R,6S)-2,4-dihydroxy-5,5-dimethyl-6-[(1E,3Z)-penta-1,3-dienyl]-3-(2-phenylacetyl)oxyoxan-2-yl]-3-[(2R,4S,5R,6S)-5-[(2R,4R,5S,6S)-5-[(2S,4S,5R,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxypropanoyl]amino]-3-methoxy-4-methylocta-4,6-dien-2-yl]-3-hydroxyoxolan-2-yl]hepta-2,4,6-trienoic acid

Ganefromycin component (α)